Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for chronic ischemic digital pain in end-stage renal failure
2012-001586-32Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of capsaicin in chronic limb-threatening ischemia (CLTI) and Neuralgia, sponsored by NHS Greater Glasgow and Clyde. Started Oct 2012; status: completed.
02
Drugs
capsaicin
03
Conditions
chronic limb-threatening ischemia (CLTI)Neuralgia
Beyond the preview
Go deeper on 2012-001586-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001586-32.